Orchid Pharma Cash Flow
- Market cap
- ₹4,933 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹700.31 – ₹1,313.08
In the year ended FY25, Orchid Pharma generated ₹296 crore from operating activities, invested ₹197 crore and paid out ₹74 crore on financing activities. Net cash flow for the year was ₹24.67 crore. Free cash flow was ₹123 crore.
Orchid Pharma cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 296 |
| Cash from investing activities | -197 |
| Cash from financing activities | -74 |
| Net cash flow | 24.67 |
| Capital expenditure | 173 |
| Free cash flow | 123 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Orchid Pharma cash flow — frequently asked questions
What is Orchid Pharma's operating cash flow?
Orchid Pharma's cash flow from operating activities was ₹296 crore in the year ended FY25.
What is Orchid Pharma's free cash flow?
Orchid Pharma's free cash flow — operating cash flow minus capital expenditure — was ₹123 crore in FY25, after capital expenditure of ₹173 crore.
How much did Orchid Pharma spend on investing activities?
Net cash used in investing activities was ₹197 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Orchid Pharma With ATS
Track ORCHPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.